125 research outputs found
Alimentation and nutrition applied to the new fitness disciplines in Italian gym
No full textBackground: The energy balance between inputs and outputs is essential to avoid a reduction in performance, recovery difficulties, hormonal problems, an increased risk of fatigue, injuries and illnesses. Aim: The purpose of the study is to evaluate whether the energy intake assumed by non-professional sportsmen of the new fitness disciplines on the basis of the guidelines present in the literature, meets the needs required by their sporting activity. Methods: The sample consist of 20 non-competitive adult sportsmen (n.10 females; n.10 males) that were voluntarily enrolled in a gym, belonging to the various fitness disciplines: bodybuilders (n = 2); calisthenics (n = 3); crossfitters (n = 15). The subjects underwent an anamnestic-nutritional interview and used a photographic atlas to estimate the energy intake in the training day (in terms of macronutrients, micronutrients and H2O). Results: The results of the study reported: a lower energy intake, the breakdown of macronutrients was suitable for the nutritional indications reported by bibliographic sources, with the exception for protein intake that was higher than the other macronutrients; a lower intake of fibers, mono/polyunsaturated fatty acids; an higher intake of simple sugars, proteins and H2O, and by a normal parameters of carbohydrates, fats and saturated fatty acids. Conclusions: Generally the study has shown that the sample energy intake is extremely low in the training day. Therefore, it is useful to educate sportsmen, coaches and families in order to avoid deficiencies/excess of calories and nutrients which may not be functional for the sporting activity performed
Cardiac Electrical Alternans in Pregnancy: An Observational Study
No full textIn pregnancy, if the woman has a cardiovascular disease, her fetus has an increased risk of inherited cardiac genetic disorders. Aim of this study was to evaluate electrocardiographic alternans (ECGA, mu V) of 23 pregnant women, comparing 12 mothers of fetuses with normal rhythm (MumNRF) and 11 mothers of arrhythmic fetuses (MumArrF). ECGA is a noninvasive cardiac electrical risk marker able to reveal heart electrical instability. ECGA manifests in the ECG as P-wave alternans (PWA), QRS alternans (QRSA) and/or T-wave alternans (TWA). Analysis was performed by the enhanced adaptive matched filter method. ECGA distributions were expressed as: median (interquartile range). Comparisons were performed by the Wilcoxon rank-sum test. Although showing similar heart rate (MumNRF: 85 (19) bpm; MumArrF: 90 (13) bpm), ECGA was higher in MumArrF population than MumNRF one (PWA: 9 (7) mu V vs. 14 (14) mu V; QRSA: 9 (10) mu V vs. 17 (16) mu V, TWA: 12 (14) mu Vvs. 28(17) mu V), but only TWA distributions were statistically different. Moreover, TWA was higher than in a female healthy population (on average 18mu V)in 70% of MumArrF, vs. 33% of MumNRF. Thus, higher TWA in our MumArrF seems to reflect a more unstable heart electrical condition of arrhythmic fetuses' mothers than normal-rhythm fetuses' mothers
Isolated amyloid-β pathology is associated with preserved cortical plasticity in APOE4 Alzheimer's disease patients
No full textBackground: Long-term potentiation (LTP) like-cortical plasticity impairment and cholinergic neurotransmission deficits have been widely demonstrated in Alzheimer's disease (AD) patients.
Objective: In this study we aim to investigate the neurophysiological features underlying cognitive decline in AD patients according to the National Institute on Aging-Alzheimer's Association (NIA-AA) classification and APOE genotype.
Methods: 65 newly diagnosed AD patients were enrolled. APOE genotype and lumbar puncture for the analysis of cerebrospinal fluid biomarkers were performed for diagnostic purposes. Patients were subdivided upon NIA-AA criteria, according to the presence of biomarkers of Aβ amyloid deposition (A) and fibrillar tau (T), in four groups: A+/T-E4 (n = 9), A+/T-E3 (n = 18), A+/T+ E4 (n = 21), and A+/T+ E3 (n = 17). We applied intermittent theta burst stimulation over the primary motor cortex to assess LTP-like cortical plasticity and short latency afferent inhibition (SAI) protocol to investigate central cholinergic activity. Patients were followed over 24 months. Cognitive decline was evaluated considering changes in Mini-Mental State Examination scores respect to the baseline.
Results: A+/T-E4 patients showed preserved LTP-like cortical plasticity as compared to A+/T-E3 and to A+/T+ patients independently from genotype (p < 0.001). In addition, A+/T-E4 patients showed a slower cognitive decline with respect to A+/T+ E4 (-0.5±2.12 versus -6.05±4.95; post-hoc p = 0.004) and to A+/T+ E3 patients (-4.12±4.14; post-hoc p = 0.028). No differences were found for SAI protocol (p > 0.05).
Conclusion: Our results suggest that APOE4 in patients with isolated amyloid pathology could exert positive effects on LTP-like cortical plasticity with a consequent slower cognitive decline
LTP-like cortical plasticity predicts conversion to dementia in patients with memory impairment
No full textBackground: New diagnostic criteria consider Alzheimer’s disease (AD) as a clinico-biological entity
identifiable in vivo on the presence of specific patterns of CSF biomarkers.
Objective: Here we used transcranial magnetic stimulation to investigate the mechanisms of cortical
plasticity and sensory-motor integration in patients with hippocampal-type memory impairment
admitted for the first time in the memory clinic stratified according to CSF biomarkers profile.
Methods: Seventy-three patients were recruited and divided in three groups according to the new
diagnostic criteria: 1) Mild Cognitive Impaired (MCI) patients (n ¼ 21); Prodromal AD (PROAD) patients
(n ¼ 24); AD with manifest dementia (ADD) patients (n ¼ 28). At time of recruitment all patients underwent CSF sampling for diagnostic purposes. Repetitive and paired-pulse transcranial magnetic
stimulation protocols were performed to investigate LTP-like and LTD-like cortical plasticity, short
intracortical inhibition (SICI) and short afferent inhibition (SAI). Patients were the followed up during
three years to monitor the clinical progression or the conversion to dementia.
Results: MCI patients showed a moderate but significant impairment of LTP-like cortical plasticity, while
ADD and PROAD groups showed a more severe loss of LTP-like cortical plasticity. No differences were
observed for LTD-like cortical plasticity, SICI and SAI protocols. Kaplan-Meyer analyses showed that
PROAD and MCI patients converting to dementia had weaker LTP-like plasticity at time of first evaluation.
Conclusion: LTP-like cortical plasticity could be a novel biomarker to predict the clinical progression to
dementia in patients with memory impairme
Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid
No full textAims Irritability has been described as a frequent adverse event in patients affected by epilepsy and treated with perampanel (PER), levetiracetam (LEV), and less frequently with valproic acid (VPA). Since the questionnaire for irritability (I-EPI) is a validated instrument to measure this psychiatric manifestation in patients affected by epilepsy, in this study we aimed at investigating the effect of PER as first add-on therapy on I-EPI. Moreover, we compared the effectiveness and I-EPI scores obtained at 12-month follow-up visits in patients treated by PER, LEV, or VPA in order to measure irritability as a consequence of these treatments. Methods We collected data from 17 patients treated by PER, 16 patients treated by LEV, and 16 patients under VPA treatment followed for 12 months. Results We did not document significant changes of I-EPI questionnaire between baseline and follow-up in the PER group. As concerning the comparison of I-EPI among PER, LEV, and VPA groups, we documented lower global scores in PER than both LEV (P < 0.05) and VPA (P < 0.05) groups. Moreover, patients under PER treatment showed lower scores than LEV and VPA (P < 0.05) in I-EPI items measuring the gentle personality, anxiety of having epileptic seizures in front of others, and irritability in thinking that they can have an epileptic seizure. Conclusions This retrospective study described a stable and possibly lower degree of irritability in patients starting PER than LEV and VPA treatments, although we documented the comparable effectiveness of PER, LEV, and VPA as first add-on treatments in patients affected by uncontrolled epileptic seizures. However, the small sample of patients included in this study and the absence of I-EPI scores obtained at baseline visits in LEV and VPA groups require further investigations to confirm this preliminary evidence
Ketanserin alone and in combination with enalapril in the treatment of essential hypertension: assessment of the haemodynamic effects
No full textThe antihypertensive and haemodynamic efficacies of ketanserin and ketanserin plus enalapril were compared. The monotherapy phase of the study involved the oral administration of 40 mg ketanserin twice daily or 20 mg enalapril once daily for 12 weeks to 25 hypertensive patients. Systolic and diastolic blood pressures were significantly reduced by both drugs. Left ventricular function both at rest and during effort improved significantly with either drug. This was due to a reduction of end-systolic volume; end-diastolic volume decreased only with the use of enalapril. Combination therapy, involving 16 patients and both drugs given at the original dosage schedule for 12 weeks, resulted in further reductions in systolic and diastolic blood pressures, and an improvement in left ventricular function; indices of diastolic function were not modified. In conclusion, ketanserin and enalapril showed comparable antihypertensive and haemodynamic activities. A combination of ketanserin and enalapril increased the favourable characteristics of both drugs
Gender specific decrease of a set of circulating N-acylphosphatidyl ethanolamines (NAPEs) in the plasma of Parkinson’s disease patients
No full textIntroduction
Current markers of Parkinson’s disease (PD) fail to detect the early progression of disease state. Conversely, current omics techniques allow the investigation of hundreds of molecules potentially altered by disease conditions. Based on evidence previously collected by our group in a mouse model of PD, we speculated that a particular set of circulating lipids might be significantly altered by the pathology.
Objectives
The aim of current study was to evaluate the potential of a particular set of N-acyl-phosphatidylethanolamines (NAPEs) as potential non-invasive plasma markers of ongoing neurodegeneration from Parkinson’s disease in human subjects.
Methods
A panel of seven NAPEs were quantified by LC–MS/MS in the plasma of 587 individuals (healthy controls, n = 319; Parkinson’s disease, n = 268); Random Forest classification and statistical modeling was applied to compare Parkinson’s disease versus controls. All p-values obtained in different tests were corrected for multiplicity by controlling the false discovery rate (FDR).
Results
The results indicate that this panel of NAPEs is able to distinguish female PD patients from the corresponding healthy controls. Further to this, the observed downregulation of these NAPEs is in line with the results in plasma of a mouse model of Parkinson’s (6-OHDA).
Conclusions
In the current study we have shown the downregulation of NAPEs in plasma of PD patients and we thus speculate that these lipids might serve as candidate biomarkers for PD. We also suggest a molecular mechanism, explaining our findings, which involves gut microbiota
Gender specific decrease of a set of circulating Nacylphosphatidyl ethanolamines (NAPEs) in the plasma of Parkinson’s disease patients
No full textIntroduction: Current markers of Parkinson's disease (PD) fail to detect the early progression of disease state. Conversely, current omics techniques allow the investigation of hundreds of molecules potentially altered by disease conditions. Based on evidence previously collected by our group in a mouse model of PD, we speculated that a particular set of circulating lipids might be significantly altered by the pathology.
Objectives: The aim of current study was to evaluate the potential of a particular set of N-acyl-phosphatidylethanolamines (NAPEs) as potential non-invasive plasma markers of ongoing neurodegeneration from Parkinson's disease in human subjects.
Methods: A panel of seven NAPEs were quantified by LC-MS/MS in the plasma of 587 individuals (healthy controls, n = 319; Parkinson's disease, n = 268); Random Forest classification and statistical modeling was applied to compare Parkinson's disease versus controls. All p-values obtained in different tests were corrected for multiplicity by controlling the false discovery rate (FDR).
Results: The results indicate that this panel of NAPEs is able to distinguish female PD patients from the corresponding healthy controls. Further to this, the observed downregulation of these NAPEs is in line with the results in plasma of a mouse model of Parkinson's (6-OHDA).
Conclusions: In the current study we have shown the downregulation of NAPEs in plasma of PD patients and we thus speculate that these lipids might serve as candidate biomarkers for PD. We also suggest a molecular mechanism, explaining our findings, which involves gut microbiota
- …
